RATIONAL DESIGN OF POTENT, BIOAVAILABLE NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS

被引：0
|
作者：
ERICKSONVIITANEN, S
LAM, PYS
JADHAV, PK
EYERMANN, CJ
HODGE, CN
RU, Y
BACHELER, LT
MEEK, JL
OTTO, MJ
RAYNER, MM
WONG, YN
CHANG, CH
WEBER, PC
JACKSON, DA
SHARPE, TR
机构：
[1] DUPONT MERCK PHARMACEUT CO,DEPT VIROL RES,WILMINGTON,DE 19880
[2] DUPONT MERCK PHARMACEUT CO,DEPT CHEM & PHYS SCI,WILMINGTON,DE 19880
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1994年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [41] DENOVO DESIGN AND DISCOVERY OF POTENT, NONPEPTIDAL HIV-1 PROTEASE INHIBITORS
    LAM, PYS
    EYERMANN, CJ
    HODGE, CN
    JADHAV, PK
    RU, Y
    BACHELER, LT
    MEEK, JL
    OTTO, MJ
    RAYNER, MM
    WONG, NY
    CHANG, CH
    WEBER, PC
    JACKSON, DA
    SHARPE, TR
    ERICKSONVIITANEN, SK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 96 - MEDI
  • [42] Structure activity relationship of cyclic ureas with asymmetric P2/P2' substituents: Potent inhibitors of HIV-1 protease.
    DeLucca, GV
    Kim, UT
    Akamike, E
    Lam, P
    Clark, C
    Rodgers, J
    Wang, HS
    Ko, S
    Srivastava, A
    Tanabe, K
    Klabe, R
    Beverly
    Bacheler, L
    EricksonViitanen, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 306 - MEDI
  • [43] Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors
    Muraglia, Ester
    Kinzel, Olaf
    Gardelli, Cristina
    Crescenzi, Benedetta
    Donghi, Monica
    Ferrara, Marco
    Nizi, Emanuela
    Orvieto, Federica
    Pescatore, Giovanna
    Laufer, Ralph
    Gonzalez-Paz, Odalys
    Di Marco, Annalise
    Fiore, Fabrizio
    Monteagudo, Edith
    Fonsi, Massimiliano
    Felock, Peter J.
    Rowley, Michael
    Summa, Vincenzo
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 861 - 874
  • [44] Synthesis and evaluation of delta lactams as nonpeptide HIV-protease inhibitors
    DeLucca, GV
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (05) : 501 - 504
  • [45] The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors
    Patel, M
    Kaltenbach, RF
    Nugiel, DA
    McHugh, RJ
    Jadhav, PK
    Bacheler, LT
    Cordova, BC
    Klabe, RM
    Erickson-Viitanen, S
    Garber, S
    Reid, C
    Seitz, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (09) : 1077 - 1082
  • [46] Interpreting trends in the binding of cyclic ureas to HIV-1 protease
    Mardis, KL
    Luo, R
    Gilson, MK
    JOURNAL OF MOLECULAR BIOLOGY, 2001, 309 (02) : 507 - 517
  • [47] A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS (VOL 15, PG 535, 1994)
    WONG, YN
    BURCHAM, DL
    SAXTON, PL
    ERICKSONVIITANEN, S
    GRUBB, MF
    QUON, CY
    HUANG, SM
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1995, 16 (02) : R2 - R2
  • [48] THE APPLICATION OF COMPUTER-ASSISTED DRUG DESIGN IN THE DISCOVERY OF NONPEPTIDE HIV-1 PROTEASE INHIBITORS
    LUNNEY, EA
    HUMBLET, C
    HAGEN, SE
    TAIT, B
    WILSON, M
    DOMAGALA, JM
    HUPE, L
    FERGUSON, D
    TUMMINO, PJ
    HUPE, D
    BHAT, TN
    ERICKSON, JW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 45 - COMP
  • [49] Design and synthesis of highly potent HIV protease inhibitors with activity against protease resistant virus.
    Lu, ZJ
    Raghavan, S
    Bohn, J
    Charest, M
    Stahlhut, MW
    Rutkowski, CA
    Himmelberger, AL
    Olsen, DB
    Schleif, WA
    Carella, A
    Gabryelski, L
    Jin, LX
    Lin, JH
    Tata, JR
    Chapman, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U41 - U41
  • [50] Tricyclic ureas: A new class of HIV-1 protease inhibitors
    Han, W
    Pelletier, JC
    Hodge, CN
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) : 3615 - 3620
12345